MPO and metabolic syndrome: The reduction of the myeloperoxidase activity mediated by the LRE points to the reduction of the oxidative stress induced by dyslipidemia, since the production of this enzyme during LDLox phagocytosis produces RE, which contributes to atherogenesis [54].